Watch Part 1 on VICE.com now:
In 1998, the antiretroviral drug efavirenz was approved for treatment of HIV infection. Though the drug was highly effective, patients soon began to report bizarre dreams, hallucinations, and feelings of unreality. When South African tabloids started to run stories of efavirenz-motivated rapes and robberies, scientists began to seriously study how efavirenz might produce these unexpected hallucinogenic effects.
Hamilton Morris travels to South Africa to interview efavirenz users and dealers and study how the life-saving medicine became part of a dangerous cocktail called "nyaope."
Check out the Best of VICE here:
Subscribe to VICE here!
Check out our full video catalog:
Videos, daily editorial and more:
Like VICE on Facebook:
Follow VICE on Twitter:
Read our tumblr:
In 1998, the antiretroviral drug efavirenz was approved for treatment of HIV infection. Though the drug was highly effective, patients soon began to report bizarre dreams, hallucinations, and feelings of unreality. When South African tabloids started to run stories of efavirenz-motivated rapes and robberies, scientists began to seriously study how efavirenz might produce these unexpected hallucinogenic effects.
Hamilton Morris travels to South Africa to interview efavirenz users and dealers and study how the life-saving medicine became part of a dangerous cocktail called "nyaope."
Check out the Best of VICE here:
Subscribe to VICE here!
Check out our full video catalog:
Videos, daily editorial and more:
Like VICE on Facebook:
Follow VICE on Twitter:
Read our tumblr:
- Category
- वृत्तचित्र - Documentary
Sign in or sign up to post comments.
Be the first to comment